Jan H Loeb
CIK 1131043 · President and CEO · last filed 2026-01-21
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ACFN price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
10451 MILL RUN CIRCLE SUITE 400
OWINGS MILLS, MD 21117
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACFN | President and CEO | 515,449 | $17.12 | $8.82M | $1.73M | 31 | 2026-01-21 |
| GYRO | Director | 69,218 | $4.42 | $305.9K | $0 | 1 | 2024-03-14 |
| KID BRANDS, INC (KID) Delisted | Director | 2,073,118 | — | — | $0 | 2 | 2014-02-06 |
| PERNIX THERAPEUTICS HOLDINGS, INC. (PTX) Delisted | Director | 44,855 | — | — | $0 | 2 | 2011-06-21 |
| PERNIX THERAPEUTICS HOLDINGS, INC. (GTA) Delisted | Director | — | — | — | $0 | 2 | 2010-01-19 |
Recent Filings · Page 5 of 5
50 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2010-01-19 | PERNIX THERAPEUTICS HOLDINGS, INC. (GTA) Delisted | Buy (P) | — | $0 | EDGAR |
| 2009-11-24 | PERNIX THERAPEUTICS HOLDINGS, INC. (GTA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-11-20 | — | Gift (G) | −1,500 | $0 | |
| 2009-11-13 | — | Grant (A) | — | $0 | |
| 2008-11-05 | — | Grant (A) | — | $0 | |
| 2008-07-15 | — | Sell (S) | −1,100 | -$19.0K | |
| 2008-07-01 | — | Sell (S) | −1,973 | -$34.0K | |
| 2008-06-27 | — | Mixed | +13,920 | $0 | |
| 2008-02-08 | — | Exer (M) | +5,000 | $24.4K | |
| 2007-11-26 | — | Grant (A) | — | $0 |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.